CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
SCOPE-Chinese Womenother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04326660
NCT04326660N/ACompleted

The Smartphone-Based Cancer and Obesity Prevention Education Program for Chinese Women (SCOPE-Chinese Women)

University of California, San Francisco·interventional·Posted Mar 30, 2020·Updated Dec 22, 2022

In Brief

A clinical study evaluating SCOPE-Chinese Women for Cancer, Breast and Obesity, Abdominal. Completed, enrolled 40 participants across 2 sites in 2 countries.

Detailed Summary

This project examines the feasibility of a smartphone-based intervention to reduce obesity and breast cancer risk among Chinese women in China. The proposed intervention is to use the mobile application and an activity tracker device to promote a healthier lifestyle and physical activity. The intervention will be tailored to the participants' behaviors, personal needs, and preferences. The aim is to reduce abdominal obesity and improve healthy lifestyle behaviors in premenopausal women with children in order to reduce the growing cancer burden in China.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina, United States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMar 30, 2020
Enrollment StartJul 20, 2020
Primary CompletionDec 30, 2021
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 6.3 years ago

Interventions

SCOPE-Chinese Womenother

SCOPE-Chinese Women is a smart-phone based intervention that includes a Fitbit tracking device to monitor daily activity, 12-weeks of educational modules delivered by WeChat, and Bi-weekly messages that encourage positive behavioral change. The data will be examined by the research team to assess efficacy of the intervention.